Clinical Trial Update: Fluocinolone Implant to Treat Macular Degeneration [Phase 1]

View source ↗

Summary

An NEI-sponsored Phase 1 trial evaluating a fluocinolone implant for macular degeneration (including choroidal neovascularization) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• Fluocinolone implant (fluocinolone acetonide)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Choroidal Neovascularization, Macular Degeneration | Phase 1 | Status: COMPLETED